| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
6,747,979,000 as of 3/29 |
| Market
Cap: |
110.19(B) |
| Last
Volume: |
39,897,363 |
Avg
Vol: |
59,801,783 |
| 52
Week Range: |
$14.14 - $20 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 41 |
| Guru Rank Value : 18.9 |
| Guru Occurances : 7 |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
Company Profile Pfizer discovers, develops, produces and markets prescription medicines for humans and animals. Co. has two key segments: Pharmaceutical, which develops and produces products that treat cardiovascular and metabolic diseases, central nervous system disorders, arthritis and pain, infectious and respiratory diseases, urogenital conditions, cancer, eye disease, endocrine disorders and allergies; and Animal Health, which discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. Co. also operates several other businesses, including the manufacture of empty soft-gelatin capsules, contract manufacturing and bulk pharmaceutical chemicals.
|
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
12,728 |
26,248 |
26,248 |
196,570 |
| Total Sell Value |
$207,085 |
$414,617 |
$414,617 |
$3,082,387 |
| Total People Sold |
1 |
2 |
2 |
4 |
| Total Sell Transactions |
1 |
2 |
2 |
6 |
| End Date |
2010-06-06 |
2010-03-05 |
2009-09-04 |
2008-09-04 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Cangialosi Loretta V |
Sr. Vice President, Controller |
• – – |
2010-08-04 |
4 |
S |
$16.27 |
$207,085 |
D/D |
(12,728) |
178,899 |
|
-0% |
|
| Kindler Jeffrey B |
Chairman & CEO |
• • – |
2010-05-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,280) |
826,631 |
|
- |
|
| Mcleod Mary S |
Senior Vice President |
• – – |
2010-05-27 |
4 |
S |
$15.35 |
$207,532 |
D/D |
(13,520) |
121,832 |
|
-7% |
|
| Mcleod Mary S |
Senior Vice President |
• – – |
2010-04-30 |
4 |
D |
$16.72 |
$167,183 |
D/D |
(9,999) |
134,035 |
|
- |
|
| Lankler Douglas M |
Senior Vice PresidentOfficer |
• – – |
2010-04-01 |
3 |
|
$0.00 |
$0 |
I/I |
0 |
900 |
|
- |
|
| Lankler Douglas M |
Senior Vice PresidentOfficer |
• – – |
2010-04-01 |
3 |
|
$0.00 |
$0 |
D/D |
0 |
80,703 |
|
- |
|
| Peck Kristin C |
Senior Vice PresidentOfficer |
• – – |
2010-04-01 |
3 |
|
$0.00 |
$0 |
D/D |
0 |
30,404 |
|
- |
|
| Peck Kristin C |
Senior Vice PresidentOfficer |
• – – |
2010-04-01 |
3 |
|
$0.00 |
$0 |
I/I |
0 |
1,427 |
|
- |
|
| Kindler Jeffrey B |
Chairman & CEO |
• • – |
2010-03-18 |
4 |
|
$0.00 |
$0 |
I/I |
665 |
665 |
|
- |
|
| Susman Sally |
Senior Vice President |
• – – |
2010-02-26 |
4 |
D |
$17.55 |
$210,670 |
D/D |
(12,004) |
176,002 |
|
- |
|
| Redmond Cavan M. |
Senior Vice President |
• – – |
2010-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
22,284 |
84,350 |
|
- |
|
| Riccardi Natale S |
Senior Vice President |
• – – |
2010-02-25 |
4 |
D |
$17.69 |
$32,691 |
D/D |
(1,848) |
378,851 |
|
- |
|
| Riccardi Natale S |
Senior Vice President |
• – – |
2010-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
34,179 |
380,699 |
|
- |
|
| Read Ian C |
Senior Vice President |
• – – |
2010-02-25 |
4 |
D |
$17.69 |
$28,605 |
D/D |
(1,617) |
565,218 |
|
- |
|
| Read Ian C |
Senior Vice President |
• – – |
2010-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
89,540 |
566,835 |
|
- |
|
| Schulman Amy W |
Senior Vice President |
• – – |
2010-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
36,211 |
182,653 |
|
- |
|
| Ringo William R |
Senior Vice President |
• – – |
2010-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
13,231 |
252,798 |
|
- |
|
| Cangialosi Loretta V |
Sr. Vice President, Controller |
• – – |
2010-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
11,099 |
189,959 |
|
- |
|
| Cangialosi Loretta V |
Sr. Vice President, Controller |
• – – |
2010-02-25 |
4 |
D |
$17.69 |
$18,911 |
D/D |
(1,069) |
188,890 |
|
- |
|
| Dolsten Mikael |
Senior Vice President |
• – – |
2010-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
36,212 |
137,987 |
|
- |
|
| Susman Sally |
Senior Vice President |
• – – |
2010-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
39,499 |
188,006 |
|
- |
|
| Damelio Frank A |
Senior Vice President |
• – – |
2010-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
84,959 |
454,891 |
|
- |
|
| Kindler Jeffrey B |
Chairman & CEO |
• • – |
2010-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
243,482 |
820,888 |
|
- |
|
| Mcleod Mary S |
Senior Vice President |
• – – |
2010-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
32,591 |
144,034 |
|
- |
|
| Mackay Martin |
Senior Vice President |
• – – |
2010-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
69,488 |
376,171 |
|
- |
|
387 Records found
|
|
Page 1 of 16 |
|
|
0.13 (0.79%) 
